vs

Side-by-side financial comparison of ARBOR REALTY TRUST INC (ABR) and VIEMED HEALTHCARE, INC. (VMD). Click either name above to swap in a different company.

ARBOR REALTY TRUST INC is the larger business by last-quarter revenue ($133.4M vs $76.2M, roughly 1.8× VIEMED HEALTHCARE, INC.). On growth, VIEMED HEALTHCARE, INC. posted the faster year-over-year revenue change (25.5% vs -12.1%). Over the past eight quarters, VIEMED HEALTHCARE, INC.'s revenue compounded faster (22.7% CAGR vs -8.9%).

Arbor Realty Trust Inc. is a U.S.-headquartered specialized real estate investment trust (REIT). It primarily provides structured financing solutions for multifamily residential and commercial real estate projects, including bridge loans, agency lending, and mezzanine financing. Its core market covers the U.S. real estate sector, serving property owners, developers and real estate investors nationwide.

Viemed Healthcare, Inc. is a medical technology firm specializing in respiratory care solutions. It develops, manufactures and distributes portable ventilators, respiratory therapy devices and related support services, catering to acute care, post-acute care and home care segments across North America, Europe and key Asia-Pacific markets for patients with respiratory conditions.

ABR vs VMD — Head-to-Head

Bigger by revenue
ABR
ABR
1.8× larger
ABR
$133.4M
$76.2M
VMD
Growing faster (revenue YoY)
VMD
VMD
+37.6% gap
VMD
25.5%
-12.1%
ABR
Faster 2-yr revenue CAGR
VMD
VMD
Annualised
VMD
22.7%
-8.9%
ABR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ABR
ABR
VMD
VMD
Revenue
$133.4M
$76.2M
Net Profit
$5.6M
Gross Margin
57.9%
Operating Margin
11.0%
Net Margin
7.4%
Revenue YoY
-12.1%
25.5%
Net Profit YoY
30.7%
EPS (diluted)
$0.08
$0.14

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ABR
ABR
VMD
VMD
Q4 25
$133.4M
$76.2M
Q3 25
$112.4M
$71.9M
Q2 25
$130.4M
$63.1M
Q1 25
$134.2M
$59.1M
Q4 24
$151.7M
$60.7M
Q3 24
$156.7M
$58.0M
Q2 24
$153.1M
$55.0M
Q1 24
$160.7M
$50.6M
Net Profit
ABR
ABR
VMD
VMD
Q4 25
$5.6M
Q3 25
$52.0M
$3.5M
Q2 25
$36.3M
$3.2M
Q1 25
$43.4M
$2.6M
Q4 24
$4.3M
Q3 24
$73.5M
$3.9M
Q2 24
$61.8M
$1.5M
Q1 24
$73.2M
$1.6M
Gross Margin
ABR
ABR
VMD
VMD
Q4 25
57.9%
Q3 25
57.5%
Q2 25
58.3%
Q1 25
56.3%
Q4 24
59.5%
Q3 24
59.3%
Q2 24
59.8%
Q1 24
58.9%
Operating Margin
ABR
ABR
VMD
VMD
Q4 25
11.0%
Q3 25
7.8%
Q2 25
8.1%
Q1 25
6.5%
Q4 24
10.6%
Q3 24
9.7%
Q2 24
6.6%
Q1 24
46.9%
4.4%
Net Margin
ABR
ABR
VMD
VMD
Q4 25
7.4%
Q3 25
46.3%
4.9%
Q2 25
27.8%
5.0%
Q1 25
32.3%
4.4%
Q4 24
7.1%
Q3 24
46.9%
6.7%
Q2 24
40.4%
2.7%
Q1 24
45.6%
3.2%
EPS (diluted)
ABR
ABR
VMD
VMD
Q4 25
$0.08
$0.14
Q3 25
$0.20
$0.09
Q2 25
$0.12
$0.08
Q1 25
$0.16
$0.06
Q4 24
$0.31
$0.10
Q3 24
$0.31
$0.10
Q2 24
$0.25
$0.04
Q1 24
$0.31
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ABR
ABR
VMD
VMD
Cash + ST InvestmentsLiquidity on hand
$482.9M
$13.5M
Total DebtLower is stronger
$11.1B
Stockholders' EquityBook value
$3.0B
$141.5M
Total Assets
$14.5B
$199.2M
Debt / EquityLower = less leverage
3.75×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ABR
ABR
VMD
VMD
Q4 25
$482.9M
$13.5M
Q3 25
$423.4M
$11.1M
Q2 25
$255.7M
$20.0M
Q1 25
$308.8M
$10.2M
Q4 24
$503.8M
$17.5M
Q3 24
$687.5M
$11.3M
Q2 24
$737.5M
$8.8M
Q1 24
$908.0M
$7.3M
Total Debt
ABR
ABR
VMD
VMD
Q4 25
$11.1B
Q3 25
$10.4B
Q2 25
$10.1B
Q1 25
$9.9B
Q4 24
$10.0B
Q3 24
$10.3B
Q2 24
$10.6B
Q1 24
$11.4B
Stockholders' Equity
ABR
ABR
VMD
VMD
Q4 25
$3.0B
$141.5M
Q3 25
$3.0B
$133.6M
Q2 25
$3.0B
$139.7M
Q1 25
$3.0B
$134.8M
Q4 24
$3.0B
$131.4M
Q3 24
$3.0B
$125.0M
Q2 24
$3.1B
$119.4M
Q1 24
$3.1B
$116.3M
Total Assets
ABR
ABR
VMD
VMD
Q4 25
$14.5B
$199.2M
Q3 25
$13.9B
$202.4M
Q2 25
$13.6B
$184.6M
Q1 25
$13.4B
$178.1M
Q4 24
$13.5B
$177.1M
Q3 24
$13.9B
$169.5M
Q2 24
$14.2B
$163.9M
Q1 24
$15.1B
$154.9M
Debt / Equity
ABR
ABR
VMD
VMD
Q4 25
3.75×
Q3 25
3.47×
Q2 25
3.40×
Q1 25
3.29×
Q4 24
3.29×
Q3 24
3.40×
Q2 24
3.47×
Q1 24
3.68×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ABR
ABR
VMD
VMD
Operating Cash FlowLast quarter
$372.4M
$18.4M
Free Cash FlowOCF − Capex
$9.7M
FCF MarginFCF / Revenue
12.7%
Capex IntensityCapex / Revenue
11.5%
Cash ConversionOCF / Net Profit
3.27×
TTM Free Cash FlowTrailing 4 quarters
$11.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ABR
ABR
VMD
VMD
Q4 25
$372.4M
$18.4M
Q3 25
$178.7M
$18.4M
Q2 25
$60.0M
$12.3M
Q1 25
$150.5M
$2.9M
Q4 24
$461.5M
$15.0M
Q3 24
$85.0M
$12.7M
Q2 24
$69.9M
$10.2M
Q1 24
$260.0M
$1.2M
Free Cash Flow
ABR
ABR
VMD
VMD
Q4 25
$9.7M
Q3 25
$10.7M
Q2 25
$4.1M
Q1 25
$-12.6M
Q4 24
$3.2M
Q3 24
$1.7M
Q2 24
$1.2M
Q1 24
$-4.8M
FCF Margin
ABR
ABR
VMD
VMD
Q4 25
12.7%
Q3 25
14.9%
Q2 25
6.5%
Q1 25
-21.4%
Q4 24
5.2%
Q3 24
3.0%
Q2 24
2.3%
Q1 24
-9.5%
Capex Intensity
ABR
ABR
VMD
VMD
Q4 25
11.5%
Q3 25
10.6%
Q2 25
12.9%
Q1 25
26.2%
Q4 24
19.5%
Q3 24
19.0%
Q2 24
16.3%
Q1 24
11.9%
Cash Conversion
ABR
ABR
VMD
VMD
Q4 25
3.27×
Q3 25
3.44×
5.23×
Q2 25
1.65×
3.88×
Q1 25
3.47×
1.09×
Q4 24
3.47×
Q3 24
1.16×
3.29×
Q2 24
1.13×
6.94×
Q1 24
3.55×
0.73×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons